Items tagged with Treatment

The use of bedaquiline in regimens to treat drug-resistant and drug-susceptible tuberculosis: a perspective from tuberculosis-affected communities (post with simple image)

Community voices on bedaquiline's use to treat drug-resistant tuberculosis and future development as a potential treatment for drug-susceptible disease have been largely unheard.

Swaziland: Surviving drug-resistant TB: “I’m still over the moon” (post with simple image)

Ninety-nine patients in Swaziland who successfully completed their treatment for drug-resistant tuberculosis have been presented with certificates by Médecins Sans Frontières (MSF) saying “I got tested and cured of TB”.

Reduced treatment delays for people with drug-resistant TB and HIV co-infection through decentralised care and rapid Xpert MTB/RIF test (post with simple image)

Decentralisation of drug-resistant tuberculosis (DR-TB) management and use of the Xpert MTB/RIF test improves the time from clinic presentation to treatment from 50 days to 7 days in a population with a high burden of HIV and TB co-infection, according to a study from Khayelitsha, South Africa, presented at the 20th International AIDS Conference (AIDS 2014) on Monday.

New TB drug bedaquiline: Weighing the benefits against the risks (post with simple image)

Laia Ruiz Mingote and Dorothy Namutamba—co-chairs of CRAG— and Mike Watson Frick—TB/HIV Program Officer at Treatment Action Group—discuss the benefits and risks of using bedaquiline to treat TB.

South Africa: Drug-resistant TB patients lost in the system (post with simple image)

Mpumalanga patients with drug-resistant TB say health workers at specialist TB hospitals in Standerton and Barberton keep them in the dark about their diagnosis and treatment.

What does new drug PaMZ mean for TB and HIV treatment? (post with simple image)

The development of PaMZ has been hailed as a breakthrough. But what do the experts think?

Attempt to shorten standard tuberculosis treatment fails in REMoxTB trial (post with simple image)

Two 4-month treatment regimens containing moxifloxacin are less effective than the standard 6-month regimen for drug-sensitive tuberculosis.

WHO/Europe: New expert opinion document (post with simple image)

The role of surgery in the treatment of pulmonary TB and multidrug- and extensively drug-resistant TB

UNITAID Tuberculosis Medicines Technology and Market Landscape (second edition) (post with simple image)

The report details current shortcomings in the tuberculosis medicines market and opportunities to improve access to lifesaving TB treatment.

Short TB regimens fall flat (post with simple image)

Two short treatment regimens for tuberculosis failed to match the standard 6 months of therapy in efficacy.

Page 52 of 62 · Total posts: 0

←First 51 52 53 Last→